Disease course heterogeneity and OCT in multiple sclerosis

Background: The heterogeneity of the disease course in multiple sclerosis (MS) remains a challenge for patient management and clinical trials. Objective: The objective of this paper is to investigate the relationship between disease course heterogeneity and retinal layer thicknesses in MS. Methods: A total of 230 MS patients and 63 healthy control subjects were included. Spectral-domain OCT scanning of the peripapillary and macular regions was performed, followed by automated eight-layer segmentation. Generalised estimation equations were used for comparisons. Receiver operating characteristic (ROC) curves were calculated for distinguishing a benign from a typical disease course. Results: Primary progressive patients showed relative preservation of inner retinal layers, compared to the relapsing onset MS types. Only in MS eyes without optic neuritis did patients with typical MS show more severe thinning of the inner retinal layers (RNFL to INL) compared to patients with a benign disease course, even after an average disease course of 20 years. Conclusion: The thicknesses, particularly of the innermost retinal layers (RNFL, GCC), were significantly related to the heterogeneous disease course in MS. The relative preservation of these layers in primary progressive and benign MS suggests rather limited susceptibility of the retina to neurodegeneration, which may be relevant for future neurodegenerative treatment trials employing OCT as a secondary outcome measure in primary progressive MS.

[1]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.

[2]  J. Schuman,et al.  Optical coherence tomography. , 2000, Science.

[3]  M Rovaris,et al.  MRI features of benign multiple sclerosis , 2009, Neurology.

[4]  A J Thompson,et al.  Diagnostic criteria for primary progressive multiple sclerosis: A position paper , 2000, Annals of neurology.

[5]  Eliza M. Gordon-Lipkin,et al.  Optical coherence tomography and disease subtype in multiple sclerosis , 2007, Neurology.

[6]  R. Rudick,et al.  Gray matter atrophy in multiple sclerosis: A longitudinal study , 2008, Annals of neurology.

[7]  Lublin Fd,et al.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .

[8]  Axel Petzold,et al.  Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis , 2010, The Lancet Neurology.

[9]  M. Esiri,et al.  Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. , 2004, Brain : a journal of neurology.

[10]  David H. Miller,et al.  An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. , 2007, Brain : a journal of neurology.

[11]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[12]  A. Thompson,et al.  Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. , 1990, BMJ.

[13]  S. A. Meyer,et al.  Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness , 2011, Multiple sclerosis.

[14]  Hans Lassmann,et al.  Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.

[15]  J. Correale,et al.  Benign Multiple Sclerosis: Does it exist? , 2012, Current Neurology and Neuroscience Reports.

[16]  D. Goodin,et al.  Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes , 2012, PloS one.

[17]  David H. Miller,et al.  Primary-progressive multiple sclerosis , 2007, The Lancet Neurology.

[18]  F. Paul,et al.  Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography , 2012, Multiple sclerosis international.

[19]  F. Barkhof,et al.  Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. , 2002, Archives of neurology.

[20]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[21]  A. Thompson,et al.  Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis , 2004, Multiple sclerosis.

[22]  J. De Keyser,et al.  Benign course in multiple sclerosis: a review , 2006, Acta neurologica Scandinavica.

[23]  C. Polman,et al.  A dam for retrograde axonal degeneration in multiple sclerosis? , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  R. Hintzen,et al.  Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry , 2010, Journal of Neurology.

[25]  Massimiliano Calabrese,et al.  Measurement and clinical effect of grey matter pathology in multiple sclerosis , 2012, The Lancet Neurology.

[26]  David H. Miller,et al.  Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis , 2004 .

[27]  M. Freedman,et al.  Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes , 2009, Journal of the Neurological Sciences.

[28]  R. Bakshi,et al.  Cerebral pseudoatrophy or real atrophy after therapy in multiple sclerosis. , 2010, Annals of neurology.

[29]  M. Battaglini,et al.  Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes , 2010, Neurology.

[30]  A. Thompson,et al.  Major differences in the dynamics of primary and secondary progressive multiple sclerosis , 1991, Annals of neurology.

[31]  P. Albrecht,et al.  Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography , 2012, Multiple sclerosis.

[32]  M. Rovaris,et al.  Magnetic resonance-based techniques for the study and management of multiple sclerosis. , 2003, British medical bulletin.

[33]  S. A. Meyer,et al.  Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning , 2013, Neurology.

[34]  David H. Miller,et al.  Imaging outcomes for neuroprotection and repair in multiple sclerosis trials , 2009, Nature Reviews Neurology.

[35]  Axel Petzold,et al.  The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment , 2012, PloS one.